Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis

Molecular Microbiology

Volumn 79, Issue 6, 2011, Pages 1615-1628

  Ando, Hiroki ^a   Kitao, Tomoe ^a   Miyoshi Akiyama, Tohru ^a   Kato, Seiya ^b   Mori, Toru ^b   Kirikae, Teruo ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINOSALICYLIC ACID; ARGININE; BACTERIAL PROTEIN; CYCLOSERINE; ENVIOMYCIN; ETHAMBUTOL; ETHIONAMIDE; GLYCINE; ISONIAZID; KANAMYCIN; KATG PROTEIN; LEVOFLOXACIN; MYCOLIC ACID; PROTEIN INHA; RIFAMPICIN; STREPTOMYCIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CONTROLLED STUDY; DOWN REGULATION; FABG1 GENE; FURA GENE; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SEQUENCE; INHA GENE; KATG GENE; NONHUMAN; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; CELL LINE; DOWN-REGULATION; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 79952397786     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/j.1365-2958.2011.07547.x     Document Type: Article

References (31)

1. Alland, D., Steyn, A.J., Weisbrod, T., Aldrich, K., and Jacobs, W.R., Jr (2000) Characterization of the Mycobacterium tuberculosis iniBAC promoter, a promoter that responds to cell wall biosynthesis inhibition. J Bacteriol 182: 1802-1811.
2. Ando, H., Kondo, Y., Suetake, T., Toyota, E., Kato, S., Mori, T., and Kirikae, T. (2010) Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 54: 1793-1799.
3. Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K.S., Wilson, T., etal. (1994) inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263: 227-230.
4. Bardou, F., Raynaud, C., Ramos, C., Laneelle, M.A., and Laneelle, G. (1998) Mechanism of isoniazid uptake in Mycobacterium tuberculosis. Microbiology 144: 2539-2544.
5. Barton, H.A., Johnson, Z., Cox, C.D., Vasil, A.I., and Vasil, M.L. (1996) Ferric uptake regulator mutants of Pseudomonas aeruginosa with distinct alterations in the iron-dependent repression of exotoxin A and siderophores in aerobic and microaerobic environments. Mol Microbiol 21: 1001-1017.
6. Bernstein, J., Lott, W.A., Steinberg, B.A., and Yale, H.L. (1952) Chemotherapy of experimental tuberculosis. V. Isonicotinic acid hydrazide (nydrazid) and related compounds. Am Rev Tuberc 65: 357-364.
7. Caminero, J.A. (2010) Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding. Int J Tuberc Lung Dis 14: 382-390.
8. Espinal, M.A., Laszlo, A., Simonsen, L., Boulahbal, F., Kim, S.J., Reniero, A., etal. (2001) Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 344: 1294-1303.
9. Fujiki, A. (2001) TB Bacteriology Examination to Stop TB. Tokyo: The Research Institute of Tuberculosis.
10. Gouet, P., Courcelle, E., Stuart, D.I., and Metoz, F. (1999) ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics 15: 305-308.
11. Kong, D., and Kunimoto, D.Y. (1995) Secretion of human interleukin 2 by recombinant Mycobacterium bovis BCG. Infect Immun 63: 799-803.
12. Lee, A.S., Lim, I.H., Tang, L.L., Telenti, A., and Wong, S.Y. (1999) Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore. Antimicrob Agents Chemother 43: 2087-2089.
13. Lee, A.S., Teo, A.S., and Wong, S.Y. (2001) Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 45: 2157-2159.
14. NCCLS (2003) Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard. NCCLS document M24-A, Wayne, PA: NCCLS.
15. 5 and potential use in restriction fragment length polymorphism typing of Mycobacterium tuberculosis. J Clin Microbiol 42: 3538-3548.
16. Pohl, E., Haller, J.C., Mijovilovich, A., Meyer-Klaucke, W., Garman, E., and Vasil, M.L. (2003) Architecture of a protein central to iron homeostasis: crystal structure and spectroscopic analysis of the ferric uptake regulator. Mol Microbiol 47: 903-915.
17. Pym, A.S., Domenech, P., Honore, N., Song, J., Deretic, V., and Cole, S.T. (2001) Regulation of catalase-peroxidase (KatG) expression, isoniazid sensitivity and virulence by furA of Mycobacterium tuberculosis. Mol Microbiol 40: 879-889.
18. Safi, H., Fleischmann, R.D., Peterson, S.N., Jones, M.B., Jarrahi, B., and Alland, D. (2010) Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis. Antimicrob Agents Chemother 54: 103-108.
19. Sala, C., Forti, F., Di Florio, E., Canneva, F., Milano, A., Riccardi, G., and Ghisotti, D. (2003) Mycobacterium tuberculosis FurA autoregulates its own expression. J Bacteriol 185: 5357-5362.
20. Sala, C., Forti, F., Magnoni, F., and Ghisotti, D. (2008) The katG mRNA of Mycobacterium tuberculosis and Mycobacterium smegmatis is processed at its 5' end and is stabilized by both a polypurine sequence and translation initiation. BMC Mol Biol 9: 33.
21. Sekiguchi, J., Miyoshi-Akiyama, T., Augustynowicz-Kopec, E., Zwolska, Z., Kirikae, F., Toyota, E., etal. (2007) Detection of multidrug resistance in Mycobacterium tuberculosis. J Clin Microbiol 45: 179-192.
22. Stover, C.K., Cruz, V.F., Fuerst, T.R., Burlein, J.E., Benson, L.A., Bennett, L.T., etal. (1991) New use of BCG for recombinant vaccines. Nature 351: 456-460.
23. Thompson, J.D., Higgins, D.G., and Gibson, T.J. (1994) clustal w: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
24. Timm, J., Lim, E.M., and Gicquel, B. (1994) Escherichia coli-mycobacteria shuttle vectors for operon and gene fusions to lacZ: the pJEM series. J Bacteriol 176: 6749-6753.
25. + ratio mediates coresistance to isoniazid and ethionamide in mycobacteria. Antimicrob Agents Chemother 49: 708-720.
26. Vilcheze, C., Wang, F., Arai, M., Hazbon, M.H., Colangeli, R., Kremer, L., etal. (2006) Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Nat Med 12: 1027-1029.
27. Wei, C.J., Lei, B., Musser, J.M., and Tu, S.C. (2003) Isoniazid activation defects in recombinant Mycobacterium tuberculosis catalase-peroxidase (KatG) mutants evident in InhA inhibitor production. Antimicrob Agents Chemother 47: 670-675.
28. WHO (2003) Guidelines for Surveillance of Drug Resistance in Tuberculosis. Geneva: WHO.
29. Zahrt, T.C., Song, J., Siple, J., and Deretic, V. (2001) Mycobacterial FurA is a negative regulator of catalase-peroxidase gene katG. Mol Microbiol 39: 1174-1185.
30. Zhang, Y., and Telenti, A. (2000) Genetics of drug resistance in Mycobacterium tuberculosis. In Molecular Genetics of Mycobacteria. Hatful, G.F., and Jacobs, W.R., Jr (eds). Washington, DC: ASM Press, pp. 235-254.
31. Zhang, Y., Heym, B., Allen, B., Young, D., and Cole, S. (1992) The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358: 591-593.